Biotheranostics announces the inclusion of Breast Cancer Index in the ASCO® Clinical Practice Guideline to help guide extended endocrine therapy decisions.
How
Do I Get
The Test?

Find your finish to anti-estrogen therapy

Breast Cancer Index® (BCI) is the only test recognized by the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and the ASCO® Clinical Practice Guideline to predict which patients are likely to benefit from extension of adjuvant anti-estrogen therapy beyond 5 years.1,2
Recently Diagnosed?On or Restarting Therapy?What the Test Tells YouFor Providers